Drug ID:   | NPD298 |
Drug Name:   | |
Molecular Formula:   | C10H15N3O |
Canonical SMILES:   | CO/N=C(/[C@H]1CN2CCC1CC2)C#N |
Standard InCHI:   | InChI=1S/C10H15N3O/c1-14-12-10(6-11)9-7-13-4-2-8(9)3-5-13/h8-9H,2-5,7H2,1H3/b12-10+/t9-/m0/s1 |
Standard InCHIKey:   | IQWCBYSUUOFOMF-QTLFRQQHSA-N |
Max Developmental Stage:   | Clinical (unspecified phase) |
Max Developmental Stage Source:   | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
Similarity Level | Similarity Score | Natural Product ID |
---|---|---|
Remote Similarity | 0.5625 | NPC151004 |
Remote Similarity | 0.5625 | NPC243635 |
Remote Similarity | 0.5625 | NPC228980 |
TTD   | DNC004272; DNC001264 |
DrugBank   | |
ChEMBL   | |
IUPHAR/BPS   | |
PharmaGKB   | |
KEGG Drug   | |
PubChem CID   | 9577995 |
ChEBI   | |
CAS Number   |
Molecular Weight   | 193.12 |
ALogP   | -1.1015 |
MLogP   | 2.12 |
XLogP   | 0.601 |
HDA   | 2 |
HBD   | 0 |
Rotatable Bonds   | 3 |
TPSA   | 48.62 |
RO5 Violation   | 0 |